Company Overview and News
Aug 16, 2018 (LBO) – Commercial Bank of Ceylon PLC has continued its growth momentum into the second quarter of 2018, despite having to pay in excess of Rs 7 billion in taxes and being compelled to make significant provisions for impairment charges for the six months ending 30th June 2018.
DUBAI (Reuters) - Qatar’s emir headed to Turkey on Wednesday for talks with President Tayyip Erdogan who is dealing with a collapse of the lira currency and deteriorating relations with the United States.
DUBAI, Aug 13 (Reuters) - Saudi Arabia’s stock index touched its lowest level in more than three months on Monday, with regional markets sinking as investors shied away from banks with links to Turkey’s deepening economic turmoil.
DUBAI, Aug 12 (Reuters) - Gulf stocks fell on Sunday, pressured by general weakness across emerging markets as investors steered clear of assets perceived as risky due to a diplomatic and economic spat between the United States and Turkey.
The Federal Reserve Bank of Dallas established the Globalization Institute in 2007 for the purpose of better understanding how the process of deepening economic integration between the countries of the world, or globalization, alters the environment in which U.S. monetary policy decisions are made.
CICHY 55BC CBQS CICHF CCB 0939
Top corporate leader and a close associate of Prime Minister Ranil Wickremesinghe, Dinesh Weerakkody is entrusted with the task of resurrecting the Sri Lanka Tourism Promotional Bureau (SLTPB), which is currently in the doldrums, Colombo Telegraph learns.
DFCC 55BC CBQS HNB
Reinforcing its market leadership and strengthening its partner base, Mobitel has joined hands with LOLC Finance PLC to offer Digital Loans for the first time ever in Sri Lanka via its mCash platform. This initiative is a break-through method of providing a loan via one’s mobile device. Digital Finance Loans is a ground-breaking product for customers who are in need of a convenient and efficient digital financing solution.
55BC CBQS LOFC
RIYADH, Aug 1 (Reuters) - Qatar’s stock market closed at its highest level for 14 months, led by banking stocks and overtaking Saudi Arabia as the top-performing index in the Gulf region while other markets were mixed amid lacklustre trading.
KUALA LUMPUR (July 31): Officials here are investigating whether the government of former Prime Minister Datuk Seri Najib Razak used funds from a China-backed infrastructure program to help pay debts owed by the state investment fund at the center of one of the world’s biggest graft probes.
Good morning, everybody. Thanks for joining us bright and early. You'll notice that in some of our key-ups for these sessions, we referred to childish names, whether it's toys or Marble Credit Card or things like that. It's because we're young at heart, and we thought you could use a bit of that first thing in the morning, at despite 160 years of history.
STAN 580001 STAB SCBFF STAN STAC 55BC 2888 3772 CBQS
2018-08-20 - Asif
Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...
2018-08-20 - Asif
Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...
2018-08-20 - Asif
General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...